Literature DB >> 11516102

Precursor-B-ALL with D(H)-J(H) gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14.

T Szczepański1, M J Willemse, E R van Wering, J F van Weerden, W A Kamps, J J van Dongen.   

Abstract

The IGH gene configuration was investigated in 97 childhood precursor-B-ALL patients at initial diagnosis. Rearrangements were found by Southern blotting in all but three patients (97%) and in 30 cases (31%) we observed oligoclonal IGH gene rearrangements. Heteroduplex PCR analysis revealed at least one clonal PCR product in all Southern blot-positive cases. In 89 patients (92%) complete V(D)J rearrangements were found, while incomplete D(H)-J(H) rearrangements occurred in only 21 patients (22%). In 5% of cases the D(H)-J(H) rearrangements were the sole IGH gene rearrangements. Sequence analysis of the 31 identified incomplete rearrangements revealed preferential usage of segments from the D(H)2, D(H)3 and D(H)7 families (78%). While D(H)2 and D(H)3 gene rearrangements occur frequently in normal B cells and B cell precursors, the relatively frequent usage of D(H)7-27 (19%) in precursor-B-ALL patients is suggestive of leukemic transformation during prenatal lymphopoiesis. Among J(H) gene segments in the incomplete D(H)-J(H) rearrangements, the J(H)6 segment was significantly overrepresented (61%). This observation together with the predominant usage of the most upstream D(H) genes indicates that many of the identified clonal D(H)-J(H) gene rearrangements in precursor-B-ALL probably represent secondary recombinations, having deleted pre-existing D(H)-J(H) joinings. The patients with incomplete D(H)-J(H) gene rearrangements were frequently characterized by hyperdiploid karyotype with additional copies of chromosome 14 and/or by IGH oligoclonality. The presence of incomplete D(H)-J(H) joinings was also significantly associated with a less mature immunogenotype: overrepresentation of V(H)6-1 gene segment usage, absence of biallelic TCRD deletions, and low frequency of TCRG gene rearrangements. This immature immunogenotype of precursor-B-ALL with incomplete IGH gene rearrangements was not associated with more aggressive disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11516102     DOI: 10.1038/sj.leu.2402206

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  17 in total

1.  Improved clonality assessment in germinal centre/post-germinal centre non-Hodgkin's lymphomas with high rates of somatic hypermutation.

Authors:  Mark A Catherwood; David Gonzalez; Caroline Patton; Edwina Dobbin; Lakshmi Venkatraman; H Denis Alexander
Journal:  J Clin Pathol       Date:  2006-06-30       Impact factor: 3.411

Review 2.  Malleable immunoglobulin genes and hematopathology - the good, the bad, and the ugly: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.

Authors:  Adam Bagg
Journal:  J Mol Diagn       Date:  2008-08-07       Impact factor: 5.568

3.  The DG75 B-cell lymphoma line exhibits biclonal immunoglobulin gene rearrangement.

Authors:  Zongli Qi; Yuan Li; Jun Hu; Hua Guo; Xiangrong Zhao; Guanghua Wang; Jinwei Gao; Qiaoxia Hu
Journal:  Biomed Rep       Date:  2012-10-12

4.  High hyperdiploid childhood acute lymphoblastic leukemia: Chromosomal gains as the main driver event.

Authors:  Kajsa Paulsson
Journal:  Mol Cell Oncol       Date:  2015-07-06

5.  Partial versus productive immunoglobulin heavy locus rearrangements in chronic lymphocytic leukemia: implications for B-cell receptor stereotypy.

Authors:  Eugenia Tsakou; Andreas Agathangelidis; Andreas Agathagelidis; Myriam Boudjoghra; Thorsten Raff; Antonis Dagklis; Maria Chatzouli; Tatjana Smilevska; George Bourikas; Helene Merle-Beral; Eleni Manioudaki-Kavallieratou; Achilles Anagnostopoulos; Monika Brüggemann; Frederic Davi; Kostas Stamatopoulos; Chrysoula Belessi
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

6.  A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining.

Authors:  Mirjam van der Burg; Hanna Ijspeert; Nicole S Verkaik; Tuba Turul; Wouter W Wiegant; Keiko Morotomi-Yano; Pierre-Olivier Mari; Ilhan Tezcan; David J Chen; Malgorzata Z Zdzienicka; Jacques J M van Dongen; Dik C van Gent
Journal:  J Clin Invest       Date:  2008-12-15       Impact factor: 14.808

7.  Evolutionary trajectories of hyperdiploid ALL in monozygotic twins.

Authors:  C M Bateman; D Alpar; A M Ford; S M Colman; D Wren; M Morgan; L Kearney; M Greaves
Journal:  Leukemia       Date:  2014-06-04       Impact factor: 11.528

8.  Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders.

Authors:  M Ladetto; M Brüggemann; L Monitillo; S Ferrero; F Pepin; D Drandi; D Barbero; A Palumbo; R Passera; M Boccadoro; M Ritgen; N Gökbuget; J Zheng; V Carlton; H Trautmann; M Faham; C Pott
Journal:  Leukemia       Date:  2013-12-17       Impact factor: 11.528

Review 9.  Minimal residual disease in acute lymphoblastic leukemia: optimal methods and clinical relevance, pitfalls and recent approaches.

Authors:  Fatemeh Salari; Mohammad Shahjahani; Saeid Shahrabi; Najmaldin Saki
Journal:  Med Oncol       Date:  2014-10-07       Impact factor: 3.064

10.  Implementation of the standard strategy for identification of Ig/TCR targets for minimal residual disease diagnostics in B-cell precursor ALL pediatric patients: Polish experience.

Authors:  Małgorzata Dawidowska; Justyna Jółkowska; Tomasz Szczepański; Katarzyna Derwich; Jacek Wachowiak; Michał Witt
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-12-01       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.